文献速递神经介入MR

未破裂颅内动脉瘤介入治疗后微栓塞事件的管壁增强预测价值

Enhancement of the parent artery plaque and aneurysm wall is associated with microembolic events after endovascular treatment of unruptured intracranial aneurysms.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-08-03

本研究前瞻性纳入159例接受血管内治疗的未破裂颅内动脉瘤患者,术前完成血管壁MRI及DWI,术后复查DWI评估新发微栓塞事件。结果显示载瘤动脉斑块强化、动脉瘤壁强化及定量强化比升高均与新发微栓塞事件独立相关,提示术前管壁成像有助于风险分层。

要点

  • 载瘤动脉斑块强化或动脉瘤壁强化者,术后DWI新发微栓塞风险升高。
  • 术前血管壁MRI可作为未破裂颅内动脉瘤介入治疗前的风险筛查手段。
  • 定量强化比升高者即使形态学不典型,也应警惕术后微栓塞事件。

核心结论

  • 载瘤动脉斑块强化和动脉瘤壁强化与未破裂颅内动脉瘤血管内治疗后微栓塞事件风险增高相关。
  • PAPE、AWE和PER均为术后新发微栓塞事件的独立相关因素。

研究设计与样本

  • 前瞻性纳入159例接受血管内治疗的未破裂颅内动脉瘤患者,共159个动脉瘤。
  • 术前MRI包括血管壁成像和DWI,术后MRI包含DWI以评估新发微栓塞事件。
  • 评估指标包括PAPE、定量PER、AWE、AER及新发微栓塞事件。
  • 采用单因素和多因素logistic回归分析筛选与微栓塞事件相关的参数。

关键影像表现/征象

  • 微栓塞事件组PAPE检出率高于无微栓塞事件组,为68.6%对14.0%。
  • 微栓塞事件组AWE检出率高于无微栓塞事件组,为63.7%对38.6%。
  • 微栓塞事件组PER中位数高于对照组,为1.2[0.5-1.6]对0.3[0.2-0.4]。
  • 微栓塞事件组AER中位数高于对照组,为1.0[0.4-1.2]对0.6[0.3-1.1]。

诊断标准与关键数值

  • PAPE独立相关于微栓塞事件的OR为3.87,95%CI为1.33-11.24,P=0.01。
  • AWE独立相关于微栓塞事件的OR为3.45,95%CI为1.43-8.32,P=0.01。
  • PER独立相关于微栓塞事件的OR为5.54,95%CI为2.09-14.64,P<0.01。
  • 在159例患者中,102例检出微栓塞事件,57例未检出微栓塞事件。

临床应用与阅片要点

  • 术前血管壁成像应重点观察载瘤动脉管壁强化和动脉瘤壁强化。
  • 存在PAPE或AWE的未破裂动脉瘤,介入治疗前需充分告知术后微栓塞风险。
  • PER升高比单纯定性判断管壁强化更能反映微栓塞事件风险。
  • 术后DWI可作为检出亚临床微栓塞事件的常规评估手段。

局限性

  • 本研究为单中心前瞻性设计,结果的外部推广性可能受限。
  • 原文未报告不同介入方式之间微栓塞事件风险的比较。
  • 原文未报告血管壁成像序列的具体参数及判读者间一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Endovascular treatment of unruptured intracranial aneurysms (UIAs) carries a potential risk of infarction due to new embolic events caused by small artery occlusion. Parent artery plaque enhancement (PAPE) and aneurysm wall enhancement (AWE) on vessel wall imaging are imaging phenotypes with multiple potential pathophysiological substrates, including but not limited to atherosclerosis. While these imaging features may reflect underlying vascular vulnerability, their relationship with postprocedural microembolic events remains unclear. The aim of this study is to investigate the relationship between PAPE or AWE on vessel wall imaging (VWI) and new microembolic events on diffusion-weighted imaging (DWI) after endovascular treatment of UIAs.

MATERIALS AND METHODS: A total of 159 patients with 159 UIAs who underwent endovascular treatment and had preoperative MRI (including VWI and DWI) and postoperative MRI (including DWI) were prospective enrolled in this study. The PAPE, quantitative parent artery plaque enhancement ratio (PER), AWE, aneurysm enhancement ratio (AER), and new microembolic events were evaluated. Univariate and multivariate logistic regression analyses identified parameters associated to microembolic events.

RESULTS: Among 159 patients with 159 UIAs, 57 patients with non-microemboli events and 102 patients with microemboli events were included in this study. Microembolic event patients had higher rates of PAPE (68.6% vs 14.0%; P < 0.001) and AWE (63.7% vs 38.6%; P =0.02), as well as greater PER (median [IQR]: 1.2 [0.5-1.6] vs 0.3 [0.2-0.4], P < 0.001) and AER (1.0 [0.4-1.2] vs 0.6 [0.3-1.1], P =0.01), compared to non-microembolic event patients. In multivariate analysis, PAPE, AWE, and PER were independent factors associated with microemboli events (OR=3.87 for PAPE [95% CI, 1.33-11.24], P=0.01; OR=3.45 for AWE [95% CI, 1.43-8.32], P=0.01; and OR=5.54 for PER [95% CI, 2.09-14.64], P< 0.01).

CONCLUSIONS: Parent artery plaque enhancement and aneurysm wall enhancement are correlated with an elevated risk of microembolic events after endovascular treatment of UIAs.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Fu, Li, Ma, et al. Enhancement of the parent artery plaque and aneurysm wall is associated with microembolic events after endovascular treatment of unruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2026. PMID: 42551954. doi:10.3174/ajnr.A9565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。